Pillar Pharmaceuticals 6 L.P. 13D/13G Filings for Aceragen, Inc. (ACGN)

Pillar Pharmaceuticals 6 L.P. 13D and 13G filings for Aceragen, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2023-08-03
4:59 pm
Sale		 2023-07-21 13D Aceragen, Inc.
ACGN		 Pillar Pharmaceuticals 6 L.P. 81,187
1.000%		 -655,295decrease
(-88.98%)		 Filing
2023-07-17
07:30 am
Sale		 2023-07-13 13D Aceragen, Inc.
ACGN		 Pillar Pharmaceuticals 6 L.P. 736,482
8.700%		 -92,639decrease
(-11.17%)		 Filing
2023-04-10
4:40 pm
Sale		 2023-04-07 13D Aceragen, Inc.
ACGN		 Pillar Pharmaceuticals 6 L.P. 829,121
9.500%		 -178,795decrease
(-17.74%)		 Filing
2023-01-30
4:30 pm
Purchase		 2023-01-17 13D Aceragen, Inc.
ACGN		 Pillar Pharmaceuticals 6 L.P. 1,007,916
11.350%		 1,007,916increase
(New Position)		 Filing